logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Vahdat, Danoosh
    Born in August 1984
    Individual (10 offsprings)
    Officer
    2019-11-12 ~ now
    OF - Director → CIF 0
  • 2
    HUMA THERAPEUTICS LIMITED
    - now 07725451
    HUMAFORHEALTH LIMITED - 2020-04-17 07725451
    MEDOPAD LTD - 2020-04-16 07725451 12538105
    21-24 Millbank, Millbank Tower, 21-24 Millbank, London, United Kingdom
    Active Corporate (9 parents, 5 offsprings)
    Person with significant control
    2019-11-12 ~ dissolved
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

MEDSUBONE LTD

Period: 2019-11-12 ~ 2024-04-02
Company number: 12309662
Registered name
MEDSUBONE LTD - Dissolved
Standard Industrial Classification
62090 - Other Information Technology Service Activities
Brief company account
Par Value of Share
Class 1 ordinary share
12022-01-01 ~ 2022-12-31
Administrative Expenses
-3,074 GBP2022-01-01 ~ 2022-12-31
-44,071 GBP2021-01-01 ~ 2021-12-31
Operating Profit/Loss
-3,074 GBP2022-01-01 ~ 2022-12-31
-44,071 GBP2021-01-01 ~ 2021-12-31
Other Interest Receivable/Similar Income (Finance Income)
30 GBP2022-01-01 ~ 2022-12-31
9 GBP2021-01-01 ~ 2021-12-31
Profit/Loss on Ordinary Activities Before Tax
-3,044 GBP2022-01-01 ~ 2022-12-31
-44,128 GBP2021-01-01 ~ 2021-12-31
Profit/Loss
-3,044 GBP2022-01-01 ~ 2022-12-31
83,672 GBP2021-01-01 ~ 2021-12-31
Comprehensive Income/Expense
-3,044 GBP2022-01-01 ~ 2022-12-31
83,672 GBP2021-01-01 ~ 2021-12-31
Debtors
127 GBP2022-12-31
7,546 GBP2021-12-31
Cash at bank and in hand
134,204 GBP2022-12-31
129,589 GBP2021-12-31
Current Assets
134,331 GBP2022-12-31
137,135 GBP2021-12-31
Net Current Assets/Liabilities
132,314 GBP2022-12-31
135,358 GBP2021-12-31
Total Assets Less Current Liabilities
132,314 GBP2022-12-31
135,358 GBP2021-12-31
Equity
Called up share capital
1 GBP2022-12-31
1 GBP2021-12-31
1 GBP2020-12-31
Retained earnings (accumulated losses)
132,313 GBP2022-12-31
135,357 GBP2021-12-31
-1,017,721 GBP2020-12-31
Equity
132,314 GBP2022-12-31
135,358 GBP2021-12-31
-1,017,720 GBP2020-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-3,044 GBP2022-01-01 ~ 2022-12-31
83,672 GBP2021-01-01 ~ 2021-12-31
Social Security Costs
24,020 GBP2021-01-01 ~ 2021-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
2,528 GBP2021-01-01 ~ 2021-12-31
Staff Costs/Employee Benefits Expense
222,547 GBP2021-01-01 ~ 2021-12-31
Average Number of Employees
22022-01-01 ~ 2022-12-31
22021-01-01 ~ 2021-12-31
Intangible Assets - Gross Cost
Goodwill
158,153 GBP2021-12-31
Patents/Trademarks/Licences/Concessions
164,997 GBP2021-12-31
Intangible Assets - Gross Cost
323,150 GBP2021-12-31
Intangible assets - Disposals
-323,150 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
158,153 GBP2021-12-31
Patents/Trademarks/Licences/Concessions
164,997 GBP2021-12-31
Intangible Assets - Accumulated Amortisation & Impairment
323,150 GBP2021-12-31
Intangible assets - Disposals and decrease in the amortization or impairment
-323,150 GBP2022-01-01 ~ 2022-12-31
Other Debtors
Current
127 GBP2022-12-31
7,546 GBP2021-12-31
Trade Creditors/Trade Payables
Current
240 GBP2022-12-31
Amounts owed to group undertakings
Current
1,777 GBP2022-12-31
1,777 GBP2021-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
-3,044 GBP2022-01-01 ~ 2022-12-31

Related profiles found in government register
  • MEDSUBONE LTD
    Info
    Registered number 12309662
    13th Floor Millbank Tower, 21-24 Millbank, London SW1P 4QP
    PRIVATE LIMITED COMPANY incorporated on 2019-11-12 and dissolved on 2024-04-02 (4 years 4 months). The status of the company number is Dissolved.
    CIF 0
  • MEDSUBONE LTD
    S
    Registered number 12309662
    13th Floor Millbank Tower, 21-24 Millbank, London, England, SW1P 4QP
    Lmiited Company in Companies House, England, England
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    VICARDIO LIMITED
    11094966
    13th Floor Millbank Tower, 21-24 Millbank, London, England
    Dissolved Corporate (5 parents)
    Person with significant control
    2019-12-23 ~ dissolved
    CIF 1 - Ownership of voting rights - 75% or more OE
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Right to appoint or remove directors OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.